Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metronomic therapy from a pharmacologist's view.

× No keyword cloud information.

7 in total

1. Mapping microvasculature with acoustic angiography yields quantifiable differences between healthy and tumor-bearing tissue volumes in a rodent model.

Authors: Ryan C Gessner; Stephen R Aylward; Paul A Dayton
Journal: Radiology Date: 2012-07-06 Impact factor: 11.105

Review 2. Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications.

Authors: Balázs Döme; Mary J C Hendrix; Sándor Paku; József Tóvári; József Tímár
Journal: Am J Pathol Date: 2007-01 Impact factor: 4.307

3. Nontoxic, fiscally responsible, future of oncology: could it be beginning in the Third World?

Authors: Giannoula Lakka Klement; Barton A Kamen
Journal: J Pediatr Hematol Oncol Date: 2011-01 Impact factor: 1.289

4. Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma.

Authors: K K Y Cham; J H E Baker; K S Takhar; J A Flexman; M Q Wong; D A Owen; A Yung; P Kozlowski; S A Reinsberg; E M Chu; C-W A Chang; A K Buczkowski; S W Chung; C H Scudamore; A I Minchinton; D T T Yapp; S S W Ng
Journal: Br J Cancer Date: 2010-06-08 Impact factor: 7.640

Metronomic therapy from a pharmacologist's view.

1. Mapping microvasculature with acoustic angiography yields quantifiable differences between healthy and tumor-bearing tissue volumes in a rodent model.

Review 2. Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications.

3. Nontoxic, fiscally responsible, future of oncology: could it be beginning in the Third World?

4. Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma.

5. The emerging low-dose therapy for advanced cancers.

6. Conceptualizing a tool to optimize therapy based on dynamic heterogeneity.

7. Generalized principles of stochasticity can be used to control dynamic heterogeneity.